{"entity":{"type":"insider","cik":"0001486359","url":"/insider/0001486359","json_url":"/insider/0001486359.json","name":"Gyuris Jeno","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":10,"first":"2012-01-30","last":"2015-01-08","span_basis":"filed_date"},"name_variants":[{"name":"Gyuris Jeno","source":"filing","n_filings":10,"first_seen":"2012-01-30","last_seen":"2015-01-08"}],"transactions":[{"id":8332445,"accession":"0001209191-15-003161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-003161","line_url":"/filing/0001209191-15-003161#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4484.0,"shares_display":"4,484","price_per_share":0.8003,"price_display":"0.80","price_state":"stated","total_value":3588.5452,"total_display":"3,588.55","total_whole":"3,589","shares_owned_after":76131.0,"shares_owned_after_display":"76,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-07","filed_date":"2015-01-08","scope":"insider"},{"id":6549159,"accession":"0001181431-14-004413","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-004413","line_url":"/filing/0001181431-14-004413#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5430.0,"shares_display":"5,430","price_per_share":1.6435,"price_display":"1.64","price_state":"stated","total_value":8924.205,"total_display":"8,924.20","total_whole":"8,924","shares_owned_after":93815.0,"shares_owned_after_display":"93,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-30","filed_date":"2014-01-30","scope":"insider"},{"id":4384516,"accession":"0001181431-13-005180","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-005180","line_url":"/filing/0001181431-13-005180#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":767.0,"shares_display":"767","price_per_share":7.7711,"price_display":"7.77","price_state":"stated","total_value":5960.4337,"total_display":"5,960.43","total_whole":"5,960","shares_owned_after":111245.0,"shares_owned_after_display":"111,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-28","filed_date":"2013-01-28","scope":"insider"},{"id":3544481,"accession":"0001181431-12-016327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-016327","line_url":"/filing/0001181431-12-016327#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":13.065,"price_display":"13.06","price_state":"stated","total_value":26130.0,"total_display":"26,130.00","total_whole":"26,130","shares_owned_after":79512.0,"shares_owned_after_display":"79,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-08","filed_date":"2012-03-12","scope":"insider"},{"id":9252488,"accession":"0001181431-12-016932","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-016932","line_url":"/filing/0001181431-12-016932#line-2","is_derivative":false,"issuer_cik":"0001486359","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001486359","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":26000.0,"total_display":"26,000.00","total_whole":"26,000","shares_owned_after":81512.0,"shares_owned_after_display":"81,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-07","filed_date":"2012-03-13","scope":"insider"},{"id":3412213,"accession":"0001181431-12-015342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-015342","line_url":"/filing/0001181431-12-015342#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":26000.0,"total_display":"26,000.00","total_whole":"26,000","shares_owned_after":81512.0,"shares_owned_after_display":"81,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-07","filed_date":"2012-03-07","scope":"insider"},{"id":9252487,"accession":"0001181431-12-016932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-016932","line_url":"/filing/0001181431-12-016932#line-1","is_derivative":false,"issuer_cik":"0001486359","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001486359","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":13.167,"price_display":"13.17","price_state":"stated","total_value":39501.0,"total_display":"39,501.00","total_whole":"39,501","shares_owned_after":83512.0,"shares_owned_after_display":"83,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-05","filed_date":"2012-03-13","scope":"insider"},{"id":3544450,"accession":"0001181431-12-014029","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-12-014029","line_url":"/filing/0001181431-12-014029#line-3","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":13.16,"price_display":"13.16","price_state":"stated","total_value":27636.0,"total_display":"27,636.00","total_whole":"27,636","shares_owned_after":86512.0,"shares_owned_after_display":"86,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-02","filed_date":"2012-03-02","scope":"insider"},{"id":3544449,"accession":"0001181431-12-014029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-014029","line_url":"/filing/0001181431-12-014029#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":13.33,"price_display":"13.33","price_state":"stated","total_value":26660.0,"total_display":"26,660.00","total_whole":"26,660","shares_owned_after":88612.0,"shares_owned_after_display":"88,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-02","scope":"insider"},{"id":3544448,"accession":"0001181431-12-014029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-014029","line_url":"/filing/0001181431-12-014029#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":13.175,"price_display":"13.18","price_state":"stated","total_value":13175.0,"total_display":"13,175.00","total_whole":"13,175","shares_owned_after":90612.0,"shares_owned_after_display":"90,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-29","filed_date":"2012-03-02","scope":"insider"},{"id":2191471,"accession":"0001181431-12-012740","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-012740","line_url":"/filing/0001181431-12-012740#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":13.08,"price_display":"13.08","price_state":"stated","total_value":13080.0,"total_display":"13,080.00","total_whole":"13,080","shares_owned_after":91612.0,"shares_owned_after_display":"91,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-28","filed_date":"2012-02-28","scope":"insider"},{"id":2191468,"accession":"0001181431-12-012740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-012740","line_url":"/filing/0001181431-12-012740#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":13.6833,"price_display":"13.68","price_state":"stated","total_value":20524.95,"total_display":"20,524.95","total_whole":"20,525","shares_owned_after":92612.0,"shares_owned_after_display":"92,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-24","filed_date":"2012-02-28","scope":"insider"},{"id":2608999,"accession":"0001181431-12-011617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-011617","line_url":"/filing/0001181431-12-011617#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":6750.0,"total_display":"6,750.00","total_whole":"6,750","shares_owned_after":94112.0,"shares_owned_after_display":"94,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-23","filed_date":"2012-02-24","scope":"insider"},{"id":2726521,"accession":"0001181431-12-004433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-004433","line_url":"/filing/0001181431-12-004433#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486359","owner_name":"Gyuris Jeno","owner_display_name":"Gyuris Jeno","owner_url":"/insider/0001486359","role":"Officer (SVP, Head of Research)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":738.0,"shares_display":"738","price_per_share":13.3658,"price_display":"13.37","price_state":"stated","total_value":9863.9604,"total_display":"9,863.96","total_whole":"9,864","shares_owned_after":78312.0,"shares_owned_after_display":"78,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-26","filed_date":"2012-01-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001325879","name":"AVEO PHARMACEUTICALS INC","url":"/issuer/0001325879","role":"Officer (SVP, Chief Scientific Officer)","n_filings":10,"first_seen":"2012-01-30","last_seen":"2015-01-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001486359","retrieved_at":"2026-08-25T20:57:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}